Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.
Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.
复制标题
DOI:
10.1016/j.drudis.2013.11.005
复制
发表时间:
2014-05
影响因子:
7.4
通讯作者:
Wong, Stephen T. C.
中科院分区:
文献类型:
--
作者:
Jin, Guangxu;Wong, Stephen T. C.
Recycling old drugs, rescuing shelved drugs and extending patents' lives make drug repositioning an attractive form of drug discovery. Drug repositioning accounts for approximately 30% of the newly US Food and Drug Administration (FDA)-approved drugs and vaccines in recent years. The prevalence of drug-repositioning studies has resulted in a variety of innovative computational methods for the identification of new opportunities for the use of old drugs. Questions often arise from customizing or optimizing these methods into efficient drug-repositioning pipelines for alternative applications. It requires a comprehensive understanding of the available methods gained by evaluating both biological and pharmaceutical knowledge and the elucidated mechanism-of-action of drugs. Here, we provide guidance for prioritizing and integrating drug-repositioning methods for specific drug-repositioning pipelines.
登录
查看更多内容
影响因子:
5.6
作者:
Crisman, Thomas J.;Parker, Christian N.;Glick, Meir
通讯作者:
Glick, Meir
影响因子:
14.9
作者:
Chatr-Aryamontri A;Breitkreutz BJ;Heinicke S;Boucher L;Winter A;Stark C;Nixon J;Ramage L;Kolas N;O'Donnell L;Reguly T;Breitkreutz A;Sellam A;Chen D;Chang C;Rust J;Livstone M;Oughtred R;Dolinski K;Tyers M
通讯作者:
Tyers M
DOI:
10.1007/s12094-006-0048-2
发表时间:
2006-07-01
期刊:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
影响因子:
--
作者:
Carnero, A
通讯作者:
Carnero, A
影响因子:
56.9
作者:
Campillos, Monica;Kuhn, Michael;Bork, Peer
通讯作者:
Bork, Peer
影响因子:
3
作者:
Bisgin H;Liu Z;Kelly R;Fang H;Xu X;Tong W
通讯作者:
Tong W